NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 – PRESS RELEASE – InterCure Ltd., a leading medical cannabis company in Israel and outside of North America, reports that, further to the company’s press release issued on Oct. 17, 2023, in which the company provided an update regarding the status of the security situation in Israel, and its impact on the company and its employees, the company is providing an additional update regarding the status of its facility in Kibbutz Nir Oz (the “Southern Israel site”).
Since Oct. 7, 2023, war situation was declared by the Israeli government. As of this date, there is limited access to the Southern Israel site, and parts of the site are being used by the Israel Defense Forces (IDF), including, among others, the IDF’s medical corps.
The company has begun the process of restoring the Southern Israel site, and the restoring efforts are advancing according to its plans. In addition, the company is working diligently with the Israeli authorities to obtain full compensation for the damages caused by the terrorist attack and the war in Gaza. The company believes, with high certainty, that it will be entitled for compensation from the Israeli governmental authorities for all direct and indirect damages suffered, as stated in the company’s previous press release.
With the leadership position in the medical cannabis market and years of operations with the community of Kibbutz Nir-Oz, the company is committed to restore and further develop the Southern Israel site. The company is also committed to support patients’ communities especially, patients living in affected and evacuated areas, casualties and IDF veterans. Bringing relief is our mission statement.
InterCure is thankful to its managers and employees for their commitment and to its strategic partners in Israel and worldwide who stand with us in this war time.
The company intends to file preliminary results for the second half of 2023 and for its full year of 2023 through the beginning of March, and to file its full financial results for 2023 during April 2024.
